ARCHIVES

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

NCI Reponses To GAO On Eppley Contract Doesn’t Pull Any Punches

September 17, 1977

The New NCI: Structure, Procedures, Advisory Boards To Change, Klausner Says

September 15, 1995

DCBD Board Approves Recompetition Concepts, Including Cell Banks, Contrast Agents, Hepatoma Resources

November 14, 1980

Changes In Labels Of Anticancer Drugs Suggested; Response Is Slow

October 8, 1976

Radium-233 Dichloride Increased Overall Survival in Phase III Trial

June 29, 2012

FCRC Committee Limited To Review Of Basic Science

November 26, 1976